Apimeds Pharmaceuticals US Inc
APUS | AMEX
$2.88
-$0.33 (-10.28%)
At close: Oct 30, 2026, 3:59 PM ET
$2.88
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 5:38 PM ET
-10.28%
(1D)No price chart data available for 1D timeframe.
Rating
15
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #1017/1028 (Top 99%)
Key Statistics
Market Data
Market Cap $4.35M
1D Range
2.84 3.11
52W Range
1.60 39.00
Valuation (TTM)
PE -0.06
PB 0.04
EV/EBITDA -0.35
Valuation (NTM)
Forward PE N/A
Forward PEG 0.00
Price Target $0.00
Cash Flow
FCF Yield -320.2%
SBC Adj. FCF Yield -321.2%
SBC Impact -0.3%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
N/A
Dil EPS 3Y | 5Y -60.1% |
N/A
FCF 3Y | 5Y -103.4% |
N/A
Returns
ROA -45.6%
ROE -59.0%
ROIC -15.9%
Financial Health
Net Debt
$14.3M
Current Ratio 0.51
Interest Coverage -4.47
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company was incorporated in 2020 and is based in Matawan, New Jersey. Apimeds Pharmac...
Sector Healthcare
Industry Biotechnology
Employees 7
IPO Date May 9, 2025
Website www.mindwavedao.com
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove APUS